2 stellar ASX growth shares analysts rate as buys

Here are a couple of exciting growth shares that have been rated as buys…

| More on:
happy investor, share price rise, increase, up

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Looking for growth shares to buy in April? Well, here's some good news!

Listed below are two growth shares that have recently been named as buys. Here's what you need to know about them:

Allkem Limited (ASX: AKE)

Allkem could be an ASX growth share to buy in April. It is the top five global lithium mining company that was formed when Galaxy Resources and Orocobre merged last year.

The company owns a collection of high-quality assets including Olaroz, Mt Cattlin, and the Sal de Vida brine project.

Importantly, Allkem is already producing lithium in large quantities. This means that it is benefiting greatly from the record lithium prices being underpinned by the clean energy transition and the adoption of electric vehicles.

Morgans is very positive on Allkem and is forecasting strong earnings growth in the coming years as its production ramps up. It has an add rating and $14.83 price target on its shares.

Pro Medicus Limited (ASX: PME)

Another ASX growth share that is highly rated is Pro Medicus. It provides industry-leading software that facilitates the clinical assessment of medical images.

Pro Medicus has been growing at a rapid clip over the last decade thanks to increasing demand for solutions that can process, transfer and store medical images and associated data efficiently. This is particularly the case given that speed and accuracy is fundamentally linked to both treatment success and commercial incentives.

Pleasingly, the company's strong form has continued in FY 2022. During the first half, Pro Medicus reported a 40.3% increase in revenue to $44.33 million and a 52.7% jump in net profit after tax to $20.68 million.

Analysts at Bell Potter were impressed and appear confident this strong form can continue. The broker is forecasting full year revenue growth of 36% in FY 2022, 19% in FY 2023, and then 33% in FY 2024.

Bell Potter has a buy rating and $55.00 price target on the company's shares.

Motley Fool contributor James Mickleboro owns Allkem Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Pro Medicus Ltd. The Motley Fool Australia owns and has recommended Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

a happy investor with a wide smile points to a graph that shows an upward trending share price
Growth Shares

Here are the top five ASX 200 shares in Macquarie's model growth portfolio

These ASX 200 shares are highly rated by analysts at Macquarie.

Read more »

a man with a wide, eager smile on his face holds up three fingers.
Growth Shares

3 ASX shares to buy in 2024 and hold for the next 10 years

Analysts think these top shares are in the buy zone right now.

Read more »

A man leans forward over his phone in his hands with a satisfied smirk on his face although he has just learned something pleasing or received some satisfying news.
Growth Shares

4 ASX growth shares I think will benefit from interest rate cuts in 2024

Not only will home loan holders rejoice, investors of these stocks could also be yelling with joy when the Reserve…

Read more »

A smiling woman sits in a cafe reading a story on her phone about Rio Tinto and drinking a coffee with a laptop open in front of her.
Growth Shares

3 of the best ASX growth shares to buy now

Analysts see plenty of upside for these buy-rated shares.

Read more »

A man and woman in an office look at a laptop and discuss investing, budget strategies or other financial concepts
Growth Shares

Here's why analysts love these buy-rated ASX 200 growth shares

There's a reason analysts are feeling bullish about these companies.

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Growth Shares

Big returns could be coming for high-flying Lovisa shares

Morgans doesn't believe it is too late to snap up this hot stock.

Read more »

Smiling young parents with their daughter dream of success.
Growth Shares

Why these ASX 200 growth shares could be top buys now

Analysts are feeling bullish about these growth stocks. Let’s see what they’re saying.

Read more »

Concept image of a man in a suit with his chest on fire.
Growth Shares

Ignore the noise and buy this hot ASX growth stock

A recent pullback may have created a buying opportunity according to Bell Potter.

Read more »